Atlas Trials

Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.

Clinical trial NCT03034473 · UNKNOWN

Trial details

NCT number
NCT03034473
Sponsor
University Medical Center Goettingen
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Locally Advanced Rectal Cancer
Start date
2011-08-01
Primary completion
2024-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.